Pdt Partners, LLC Ptc Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1 Billion
Q4 2024

A detailed history of Pdt Partners, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 92,081 shares of PTCT stock, worth $5.25 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

92,081

Previous 165,068 44.22%

Holding current value

$5.25 Million

Previous $6.12 Million 32.14%

% of portfolio

0.42%

Previous 0.6%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$34.99 - $52.07 $2.55 Million - $3.8 Million	-72,987 Reduced 44.22%	92,081 $4.16 Million
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $780,658 - $967,410	25,688 Added 18.43%	165,068 $6.12 Million
Q2 2024 Aug 15, 2024	SELL	$24.69 - $40.12 $885,358 - $1.44 Million	-35,859 Reduced 20.46%	139,380 $4.26 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $6,472 - $8,562	-268 Reduced 0.15%	175,239 $5.1 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $2.01 Million - $3.26 Million	111,112 Added 172.55%	175,507 $4.84 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $33,121 - $62,061	1,478 Added 2.35%	64,395 $1.44 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $1,898 - $2,777	-47 Reduced 0.07%	62,917 $2.56 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $2,633 - $3,371	69 Added 0.11%	62,964 $3.05 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $257,644 - $421,006	-7,684 Reduced 10.89%	62,895 $2.4 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $1.11 Million - $1.42 Million	-26,452 Reduced 27.26%	70,579 $3.54 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $78,387 - $138,494	3,062 Added 3.26%	97,031 $3.89 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $3.13 Million - $4.19 Million	93,969 New	93,969 $3.51 Million
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $7.8 Million - $11 Million	-277,609 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $357 - $558	-12 Reduced -0.0%	277,609 $9.53 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $678 - $955	20 Added 0.01%	277,621 $13 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $25 - $47	1 Added 0.0%	277,601 $9.36 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $4.85 Million - $9.05 Million	277,600 New	277,600 $7.51 Million

Others Institutions Holding PTCT

# of Institutions

257

Shares Held

72.6M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $4.08B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account